LTFS
AZN icon

Ladenburg Thalmann Financial Services’s AstraZeneca AZN Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2.75M Sell
27,741
-806
-3% -$75.9K 0.02% 726
2019
Q3 		$2.54M Buy
28,547
+1,078
+4% +$93.5K 0.02% 721
2019
Q2 		$2.27M Buy
27,469
+1,651
+6% +$129K 0.02% 745
2019
Q1 		$2.09M Sell
25,818
-79
-0.3% -$6.23K 0.02% 750
2018
Q4 		$1.97M Buy
25,897
+7,229
+39% +$565K 0.02% 672
2018
Q3 		$1.48M Sell
18,668
-4,758
-20% -$360K 0.01% 884
2018
Q2 		$1.64M Hold
23,426
– – 0.02% 782
2018
Q1 		$1.64M Buy
23,426
+4,474
+24% +$310K 0.02% 782
2017
Q4 		$1.32M Buy
18,952
+1,960
+12% +$132K 0.01% 899
2017
Q3 		$1.15M Buy
16,992
+1,448
+9% +$91.5K 0.01% 908
2017
Q2 		$1.06M Buy
15,544
+522
+3% +$34.1K 0.01% 903
2017
Q1 		$934K Buy
15,022
+700
+5% +$40.7K 0.01% 935
2016
Q4 		$788K Sell
14,322
-297
-2% -$16.9K 0.01% 970
2016
Q3 		$961K Sell
14,619
-2,328
-14% -$152K 0.01% 817
2016
Q2 		$1.03M Sell
16,947
-162
-0.9% -$9.41K 0.02% 747
2016
Q1 		$964K Buy
17,109
+514
+3% +$30.9K 0.02% 715
2015
Q4 		$1.13M Sell
16,595
-971
-6% -$63.7K 0.02% 636
2015
Q3 		$1.12M Sell
17,566
-97
-0.5% -$6.38K 0.02% 588
2015
Q2 		$1.13M Buy
17,663
+1,577
+10% +$108K 0.02% 643
2015
Q1 		$1.1M Buy
16,086
+2,162
+16% +$150K 0.02% 646
2014
Q4 		$980K Buy
13,924
+5,937
+74% +$425K 0.02% 607
2014
Q3 		$571K Buy
7,987
+66
+0.8% +$4.83K 0.02% 734
2014
Q2 		$589K Sell
7,921
-13,147
-62% -$950K 0.02% 709
2014
Q1 		$1.37M Buy
21,068
+90
+0.4% +$5.81K 0.04% 367
2013
Q4 		$1.25M Sell
20,978
-412
-2% -$22.4K 0.04% 377
2013
Q3 		$1.11M Buy
21,390
+1,997
+10% +$100K 0.04% 372
2013
Q2 		$918K Buy
+19,393
New +$988K 0.03% 423

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ladenburg Thalmann Financial Services's AZN Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its AstraZeneca (AZN) stake by 2.8% in Q4 2019, selling an estimated $75.9K and leaving 27,741 shares worth $2.75M. The position accounts for 0.02% of the portfolio, ranked #726.

Ladenburg Thalmann Financial Services first reported a position in AZN in Q2 2013 and has held it in 27 quarters since. 634 funds tracked by Wall St. Rank hold AZN as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 27,741 shares of AstraZeneca worth $2.75M as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 806 AstraZeneca shares in Q4 2019, an estimated $75.9K.
  • AstraZeneca made up 0.02% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #726 holding.
  • Ladenburg Thalmann Financial Services first reported a position in AstraZeneca in Q2 2013 and has held it in 27 quarters since.
  • 634 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.